Hinge Health Quarterly Income Statement
NYSE: HNGETechnologyEDP ServicesUSD
At close: Oct 9, 4:00 PM ET · Delayed 15 min
Hinge Health revenue and earnings
In the quarter ended Jun 30, 2026, Hinge Health generated $212.8 million in revenue, up 53.0% from the same quarter a year earlier. Net income was $43.7 million, for a net margin of 20.5% versus a median of 13.8% in the prior 5 quarters. Gross margin was 86.4% (up from 70.3%) and operating margin 19.0%.
Diluted earnings per share came in at $0.52.
Summary generated from market data by MetaCap's automated system. Methodology
Hinge Health income statement (quarterly)
| Quarter (USD) | Q2 20262026-06-30 | Q1 20262026-03-31 | Q4 20252025-12-31 | Q3 20252025-09-30 | Q2 20252025-06-30 | Q1 20252025-03-31 | Q4 20242024-12-31 | Q3 20242024-09-30 | Q2 20242024-06-30 | Q1 20242024-03-31 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 212.82M | 182.31M | 170.73M | 154.21M | 139.10M | 123.83M | 117.26M | 100.61M | 89.83M | — |
| Revenue growth (YoY) | +53.00% | +47.23% | +45.60% | +53.27% | +54.85% | — | — | — | — | — |
| Cost of Revenue | 28.87M | 28.07M | 26.70M | 28.01M | 41.34M | 23.59M | 21.17M | 21.36M | 23.21M | — |
| Gross Profit | 183.95M | 154.23M | 144.03M | 126.20M | 97.76M | 100.23M | 96.09M | 79.26M | 66.62M | — |
| Operating Expenses | 143.51M | 122.16M | 116.77M | 132.29M | 678.43M | 87.10M | 75.18M | 83.10M | 84.17M | — |
| Research & Development | 34.06M | 30.34M | 32.76M | 31.92M | 279.96M | 23.50M | 22.37M | 23.79M | 24.92M | — |
| Selling, General & Admin | 109.45M | 91.83M | 84.02M | 100.37M | 398.47M | 63.60M | 52.81M | 59.32M | 59.25M | — |
| Operating Income | 40.44M | 32.07M | 27.26M | -6.09M | -580.67M | 13.14M | 20.91M | -3.85M | -17.55M | — |
| Other Income (Expense) | 3.99M | 3.87M | 4.96M | 4.46M | 4.69M | 5.00M | 5.25M | 5.29M | 4.99M | — |
| Pretax Income | 44.43M | 35.94M | 32.22M | -1.64M | -575.98M | 18.14M | 26.16M | 1.45M | -12.56M | — |
| Income Tax | 740.00K | 814.00K | 122.00K | 206.00K | -326.00K | 998.00K | -951.00K | 1.11M | 361.00K | — |
| Net Income | 43.69M | 35.13M | 32.09M | -1.84M | -575.65M | 17.14M | 27.12M | 341.00K | -12.93M | -26.46M |
| Net Income growth (YoY) | — | +104.96% | +18.36% | -640.76% | — | — | — | — | — | — |
| EPS (Basic) | 0.55 | 0.43 | -2.56 | -0.02 | -13.10 | 7.91 | — | 0.01 | -0.96 | — |
| EPS (Diluted) | 0.52 | 0.41 | 4.04 | -0.02 | -13.10 | 1.31 | — | 0.01 | -0.96 | — |
| Shares Outstanding (Basic) | 78.97M | 78.62M | — | 78.86M | 43.93M | 15.33M | — | 13.62M | 13.53M | — |
| Shares Outstanding (Diluted) | 83.42M | 82.39M | — | 78.86M | 43.93M | 92.75M | — | 16.58M | 13.53M | — |
| EBITDA | 41.50M | 33.24M | 28.48M | -4.83M | -579.33M | 14.44M | 22.28M | -2.43M | -17.05M | — |
| Gross Margin | 86.44% | 84.60% | 84.36% | 81.84% | 70.28% | 80.95% | 81.95% | 78.77% | 74.16% | — |
| Operating Margin | 19.00% | 17.59% | 15.96% | -3.95% | -417.45% | 10.61% | 17.83% | -3.82% | -19.54% | — |
| Net Margin | 20.53% | 19.27% | 18.80% | -120.00% | -413.85% | 13.84% | 23.13% | 34.00% | -14.39% | — |
This table shows 10 quarterly periods of Hinge Health's income statement, from Q2 2026 back to Q1 2024, across 19 line items including revenue, cost of revenue, gross profit. Values in USD; B = billions, M = millions. Fiscal periods follow HNGE's reporting calendar. What is a income statement?